Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression
article
OA: bronze
CC0
⤵ 42 in-corpus citations
AI-generated summary
Dienogest inhibited immortalized human endometrial epithelial cell proliferation and suppressed cyclin D1 gene expression, similar to progesterone.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Dienogest is a specific progesterone receptor agonist with potent oral endometrial activity and is used in the treatment of endometriosis. In this study, we examined the direct effects of dienogest on the proliferation of human endometrial epithelial cells using an immortalized cell line. 5-Bromo-2'-deoxyuridine incorporation into the cells was inhibited by dienogest and by progesterone (P(4)) in dose-dependent fashion at concentrations of 10(-8) mol/l or higher. To identify the target genes of dienogest and P(4), we screened the expression of 84 genes related to cell cycle regulation by real-time polymerase chain reaction after 6 h of treatment at a concentration of 10(-7) mol/l. Results showed that only cyclin D1 expression was significantly down-regulated, although expression of the other genes did not significantly change after dienogest or P(4) treatment compared with the control. In a time-course study during the first 24 h after drug treatment, dienogest and P(4) each produced a lasting decrease in the expression of cyclin D1 mRNA, followed by a decrease in cyclin E1 mRNA but not an increase in the expression of cell cycle inhibitor genes (p21, p27 and p53). These findings suggest that dienogest directly inhibits the proliferation of human endometrial epithelial cells with suppression of cyclin D1 gene expression.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (57)
- Advances in the management of endometriosis: an update for clinicians via openalex
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Comparative Pharmacology of Newer Progestogens via openalex
- Current place of progestins in the treatment of endometriosis-related complaints via openalex
- Dating the Endometrial Biopsy via openalex
- Dienogest via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection via openalex
- Dominant Expression of Progesterone Receptor Form B mRNA in Ovarian Endometriosis via openalex
- Endometriosis: Treatment Strategies via openalex
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosis via openalex
- Hormonal Pathology of the Endometrium via openalex
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
- Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis via openalex
- Long-term use of progestogens – effects on endometriosis, adenomyosis and myomas via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- New progestagens for contraceptive use via openalex
- New Progestogens via openalex
- Pharmacological profile of progestins via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro via openalex
- The role of progestins in treating the pain of endometriosis via openalex
- W2025391956 via openalex
- W2017188316 via openalex
- W2010311608 via openalex
- W2080251208 via openalex
- W2004594777 via openalex
- W2082068040 via openalex
- W1998108444 via openalex
- W2119801679 via openalex
- W1991538165 via openalex
- W2134753968 via openalex
- W2137608289 via openalex
- W1988258332 via openalex
- W1980087584 via openalex
- W2146946844 via openalex
- W1975984713 via openalex
- W2160027012 via openalex
- W1968027882 via openalex
- W1606655713 via openalex
- W2417605371 via openalex
- W151949596 via openalex
- W4236286816 via openalex
- W4237324865 via openalex
- W4244234820 via openalex
- W4253818405 via openalex
- W4280636125 via openalex
- W2034864360 via openalex
- W4285719527 via openalex
- W2038507723 via openalex
- W2050194681 via openalex
- W2051588136 via openalex
Cited by (42)
- Modern management of endometriosis with various manifestations: Dienogest. A prospective study 2026
- High inhibition ratio and transformation index of 2 mg dienogest: further evidence for its use in endometriosis treatment 2025
- Dienogest vs. combined oral contraceptive: A systematic review and meta‐analysis of efficacy and side effects to inform evidence‐based guidelines 2025
- Pharmacokinetics and Bioequivalence of Dienogest in Healthy Bangladeshi Female Volunteers: An Open-Label, Single-Dose, Randomized, Two-Way Crossover Study 2024
- Medical Management of Ovarian Endometriomas 2023
- Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study 2022
- Role of estrogen and estrogen-related factors in endometriosis 2021
- A progestin isn’t a progestin: dienogest for endometriosis as a blueprint for future research – Review as a contribution for discussion - 2020
- Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction 2019
- What do we know about endometrioid cysts today? 2018
- Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries 2018
- Aromatase as a target for treating endometriosis 2018
- Short-term histopathological effects of dienogest therapy on ovarian endometriomas: <i>in vivo</i>, nonrandomized, controlled trial 2017
- Endometrial Presurgical Preparation 2017
- The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia 2017
- Immunohistochemical Analysis of the Effect of Dienogest on Ovarian Endometriotic Cysts 2016
- The experience of Visanne use in patients of reproductive age with external genital endometriosis 2016
- Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR 2015
- Dienogest reduces HSD17β1 expression and activity in endometriosis 2015
- Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 2015
- Drospirenone induces decidualization in human eutopic endometrial stromal cells and reduces DNA synthesis of human endometriotic stromal cells 2015
- Decorin induced by progesterone plays a crucial role in suppressing endometriosis 2014
- Improved therapeutic management of women with endometriosis 2014
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis 2014
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis 2014
- Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive: A Patient-Preference Prospective 24-Week Pilot Study 2014
- Preoperative dienogest administration facilitates accurate hysteroscopic resection of endometrial polyps by altering the endometrium. 2013
- Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β 2013
- Endometrial Preparation With Estradiol Plus Dienogest (Qlaira) for Office Hysteroscopic Polypectomy: Randomized Pilot Study 2012
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture 2012
- Progestin therapy for endometrial cancer: The potential of fourth-generation progestin (Review) 2012
- The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study 2012
- Effects of Dienogest on Surgically Induced Endometriosis in Rats after Repeated Oral Administration 2011
- Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain 2011
- The role of prostaglandin E <sub>2</sub> in endometriosis 2011
- Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells 2011
- Progestins for the Treatment of Endometriosis: An Update 2010
- Progestins for the Treatment of Endometriosis: An Update: 2010
- Progestin effects in endometriosis treatment: new research on mechanisms 2010
- Dienogest 2010
- Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system 2010
- Dienogest: an oral progestogen for the treatment of endometriosis 2010
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:05.573375+00:00
License: CC0
· commercial use OK